We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.57B
AUM Growth
+$240M
Cap. Flow
-$1.33M
Cap. Flow %
-0.05%
Top 10 Hldgs %
34.11%
Holding
1,211
New
84
Increased
525
Reduced
539
Closed
63

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.8M
2
LIN icon
Linde
LIN
+$15.3M
3
AVGO icon
Broadcom
AVGO
+$2.95M
4
AMD icon
Advanced Micro Devices
AMD
+$2.59M
5
HD icon
Home Depot
HD
+$1.46M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$6.03M
2
MSFT icon
Microsoft
MSFT
+$5.38M
3
CVX icon
Chevron
CVX
+$4.36M
4
META icon
Meta Platforms (Facebook)
META
+$4.08M
5
AAPL icon
Apple
AAPL
+$3.64M

Sector Composition

Rank Sector Weight
1 Technology 42.5%
2 Healthcare 12.67%
3 Consumer Discretionary 11.07%
4 Communication Services 9.14%
5 Financials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
251
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.41M 0.06%
16,158
+914
+6% +$81.8K
IRWD icon
252
Ironwood Pharmaceuticals
IRWD
$611M
$1.41M 0.05%
161,855
+42,371
+35% +$514K
T icon
253
AT&T
T
$165B
$1.41M 0.05%
80,037
-8,474
-10% -$145K
DNLI icon
254
Denali Therapeutics
DNLI
$3.67B
$1.41M 0.05%
68,474
+14,799
+28% +$278K
FOLD
255
DELISTED
Amicus Therapeutics
FOLD
$1.4M 0.05%
119,258
-13,148
-10% -$168K
DVAX
256
DELISTED
Dynavax Technologies
DVAX
$1.4M 0.05%
113,133
+20,142
+22% +$263K
IDYA icon
257
IDEAYA Biosciences
IDYA
$3.41B
$1.4M 0.05%
31,922
-54
-0.2% -$2.32K
ARWR icon
258
Arrowhead Research
ARWR
$12.1B
$1.4M 0.05%
48,960
-14,593
-23% -$467K
APD icon
259
Air Products & Chemicals
APD
$66.3B
$1.4M 0.05%
5,768
-285
-5% -$69.8K
ACLX
260
DELISTED
Arcellx
ACLX
$1.39M 0.05%
20,033
+1,436
+8% +$91.1K
BHVN icon
261
Biohaven
BHVN
$2.16B
$1.39M 0.05%
25,453
-19,060
-43% -$944K
MMM icon
262
3M
MMM
$89B
$1.39M 0.05%
15,664
+582
+4% +$48.3K
IOVA icon
263
Iovance Biotherapeutics
IOVA
$2.23B
$1.39M 0.05%
93,650
-108,776
-54% -$1.27M
SNDX icon
264
Syndax Pharmaceuticals
SNDX
$1.84B
$1.39M 0.05%
58,247
-6,935
-11% -$155K
ALNY icon
265
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.39M 0.05%
9,270
+938
+11% +$156K
SWKS icon
266
Skyworks Solutions
SWKS
$9.06B
$1.38M 0.05%
12,781
+1,747
+16% +$183K
RCKT icon
267
Rocket Pharmaceuticals
RCKT
$348M
$1.38M 0.05%
51,148
+16,677
+48% +$474K
CVNA icon
268
Carvana
CVNA
$43.3B
$1.38M 0.05%
78,325
-24,725
-24% -$302K
TER icon
269
Teradyne
TER
$54.8B
$1.38M 0.05%
12,198
+1,615
+15% +$168K
ALT icon
270
Altimmune
ALT
$539M
$1.37M 0.05%
+134,842
New +$1.37M
IONS icon
271
Ionis Pharmaceuticals
IONS
$9.35B
$1.37M 0.05%
31,570
+2,497
+9% +$119K
NTNX icon
272
Nutanix
NTNX
$14.9B
$1.36M 0.05%
22,022
-2,465
-10% -$142K
DOCU
273
DocuSign
DOCU
$9.63B
$1.36M 0.05%
22,764
+897
+4% +$50.6K
APH icon
274
Amphenol
APH
$188B
$1.35M 0.05%
23,390
-1,082
-4% -$56.7K
PTCT icon
275
PTC Therapeutics
PTCT
$6.37B
$1.34M 0.05%
46,145
-9,233
-17% -$259K
9 10
11
12 13

Similar funds

MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
MSL
Mackay Shields LLC New York $2.73B AUM 2.13% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return

Profund Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Profund Advisors held 1,211 positions worth $2.57B, up 10% from $2.33B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Profund Advisors's Q1 2024 filing shows 84 new, 525 increased, 539 reduced and 63 closed positions. Its largest new stake was Altimmune: 134,842 shares worth $1.37M. The largest sale was ExxonMobil, an estimated $6.03M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Profund Advisors's largest Q1 2024 buy was Altimmune: 134,842 shares worth $1.37M.
  • Profund Advisors added most to NVIDIA in Q1 2024, an estimated $18.8M increase.
  • Profund Advisors's biggest Q1 2024 reduction was ExxonMobil, cutting an estimated $6.03M.
  • Profund Advisors fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $2.18M.
  • Profund Advisors's ten largest holdings make up 34% of its $2.57B portfolio in Q1 2024.
  • Profund Advisors opened 84 new positions and closed 63 in Q1 2024.
  • Profund Advisors's portfolio value rose 10% quarter-over-quarter to $2.57B.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.